HEALEY ALS Platform Trial - Regimen I NUZ-001

NCT07410806 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ENROLLING_BY_INVITATION

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: NUZ-001
DRUG: Matching placebo

Sponsor

Merit E. Cudkowicz, MD

Collaborators

[object Object]